Overexpression of p53 associated with tumor angiogenesis, tumor cell proliferation, and prognosis in gastric carcinoma

Oncology Reports

Volumn 4, Issue 4, 1997, Pages 765-768

  Maeda, Kiyoshi ^a   Ogawa, Masafumi ^a   Chung, Yong Suk ^a   Kang, Soon Myoung ^a   Sawada, Tetsuji ^a   Onoda, Naoyoshi ^a   Nakata, Bunzo ^a   Kato, Yasuyuki ^a   Sowa, Michio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric carcinoma; p53; Prognosis; Tumor angiogenesis; Tumor cell proliferation

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; TUMOR CELL CULTURE;

EID: 0030790343     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.4.765     Document Type: Article

References (22)

1. Harris AL: Mutant p53 - The commonest genetic abnormality in human cancer? J Pathol 162: 5-6, 1990.
2. Levine AJ, Momand J and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
3. Sun X, Carstensen J, Zhang H, Stal O, Wingren S, Hatschek T and Nordenskjold S: Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340: 1369-1373, 1992.
4. Rodrigues NR, Rowan A, Smith MEF, Keer IB, Bodmer WF, Cannon JV and Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990.
5. Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Heer HW and Reuter VE: Nuclear overexpression of p53 protein in transitional-cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 85: 53-59, 1993.
6. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RCJ and Berchuck A: Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51: 2979-2984, 1991.
7. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O and Ueshima H: Clinicopathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer 58: 14-19, 1994.
8. Gasparini G, Weidner N, Bevilacqua P, Maulta S, Palma PD, Caffo O, Barbareschi M, Boracchi P, Marubini E and Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic marker in node-negative breast carcinoma. J Clin Oncol 13: 477-481, 1995.
9. Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowicz E, Guillem JG, Cordon-Cardo C and Cohen AM: p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 12: 2043-2050, 1994.
10. Ambros RA, Vigna PA, Figge J, Kallakury BVS, Matrangelo A, Eastman AY, Malfetano J, Figge HL and Ross JS: Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Cancer 73: 1686-1692, 1994.
11. Vogelstein B and Kinzle KW: p53 function and dysfunction. Cell 70: 523-526, 1992.
12. Dameron KM, Volpert OV, Tainsky MA and Bouck N: Control of angiogenesis fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584, 1994.
13. Kieser A, Weich HA, Brandner G, Marme D and Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994.
14. Japanese Research Society for Gastric Cancer: The general rules for gastric cancer study. Jpn J Surg 11: 127-139, 1981.
15. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, Onod N, Kato Y, Nitta A, Arimoto Y, Kondo Y and Sowa M: Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13: 477-481, 1995.
16. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, Onod N, Kato Y, Nitta A, Arimoto Y, Kondo Y Sowa M: Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 72: 319-323, 1995.
17. Cox DR: Regression models and life tables. J Roy Statist Soc Ser B Meth 34: 187-220, 1972.
18. Garcia RL, Coltrera MD and Gown AM: Analysis of proliferative grade using anti PCNA/cyclin in fixed, embedded tissues. Am J Pathol 134: 733-739, 1989.
19. Allred DC, Clark GM, Elledge R, Isola J, Visakorpi, Holli K and Kallioniemi OP: Association of overexpression of tumor-suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 85: 200-206, 1993.
20. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71, 1992.
21. Weidner N, Folkman J, Pozza F, Bevilaqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1877, 1992.
22. Yonemura Y, Kimura K, Fushida Y, Tsugawa K, Nakai Y, Kaji M, Fonseca L, Yamaguchi A and Miyazaki I: Analysis of proliferative activity using anti-proliferative cell nuclear antigen in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 71: 2448-2453, 1993.